Cargando…

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting

Detalles Bibliográficos
Autores principales:	Cates, L., Crudu, V., Codreanu, A., Ciobanu, N., Fosburgh, H., Cohen, T., Menzies, N. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union Against Tuberculosis and Lung Disease 2021
Materias:	Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948759/ https://www.ncbi.nlm.nih.gov/pubmed/33688812 http://dx.doi.org/10.5588/ijtld.20.0586

Ejemplares similares

Costs of treating multidrug-resistant TB in California in 2022
por: Katrak, S., et al.
Publicado: (2023)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era
por: Zokufa, N., et al.
Publicado: (2021)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

What Research Is Needed to Stop TB? Introducing the TB Research Movement
por: Lienhardt, Christian, et al.
Publicado: (2011)

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
por: Mohr-Holland, E., et al.
Publicado: (2021)

Towards quality adolescent-friendly services in TB care
por: Laycock, K. M., et al.
Publicado: (2021)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients
por: Pan, Sheng-Wei, et al.
Publicado: (2023)

Criminal Justice Reform as HIV and TB Prevention in African Prisons
por: Todrys, Katherine W., et al.
Publicado: (2012)

Active case-finding for TB among incarcerated women in Peru
por: Puma, D., et al.
Publicado: (2023)

Multidrug-Resistant TB in the Philippines: Totem and Taboo
por: Portero, Jose Luis, et al.
Publicado: (2006)

Multidrug-Resistant TB in the Philippines: Authors' Reply
por: Tupasi, Thelma
Publicado: (2006)

Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings
por: Sloan, Derek J., et al.
Publicado: (2016)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
por: Muniyandi, Malaisamy, et al.
Publicado: (2023)

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB
por: Zeng, C., et al.
Publicado: (2023)

Costs of TB services in India
por: Chatterjee, S., et al.
Publicado: (2021)

Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines
por: Feuth, T., et al.
Publicado: (2021)

High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
por: Koirala, S., et al.
Publicado: (2021)

A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB
por: Potter, J L, et al.
Publicado: (2015)

An e-registry for household contacts exposed to multidrug resistant TB in Mongolia
por: Naker, Kush, et al.
Publicado: (2020)

Patterns of Treatment Interruption among Patients with Multidrug-Resistant TB (MDR TB) and Association with Interim and Final Treatment Outcomes
por: Podewils, Laura Jean, et al.
Publicado: (2013)

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study
por: Dirie, Abdirahman Mohamed Hassan, et al.
Publicado: (2022)

Cost of TB services: approach and summary findings of a multi-country study (Value TB)
por: Sweeney, S., et al.
Publicado: (2022)

Multidrug-Resistant TB as A Major Concern for Tuberculosis Control Programs
por: KHAZAEI, Salman, et al.
Publicado: (2016)

Lessons from Jonathan Mann: The Ten Commandments on Multidrug-Resistant TB
por: Kirby, Michael
Publicado: (2016)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Cost of TB services in healthcare facilities in Kenya
por: Kairu, A., et al.
Publicado: (2021)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia—an observational cohort study
por: Meressa, Daniel, et al.
Publicado: (2015)

The high costs facing TB-affected households in Mali
por: Traore, M., et al.
Publicado: (2022)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2020)

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications
por: Rich, M. L., et al.
Publicado: (2023)

Cost of TB prevention and treatment in the Philippines in 2017
por: Capeding, T. P. J., et al.
Publicado: (2022)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_spufhllf2thqt3qt7smkmr0ps5